GREEN PLANET MICROCAPS
ESG MICROCAP SPECIALISTS
Our treasure chest is filled with inspiring young companies that have innovative solutions to address a clean, low-carbon environment and to provide disruptive technologies to make life better
TOMORROW'S WINNERS TODAY
UltraShear Makes CBD, THC, Pharmaceuticals, Cosmetics and Nutraceuticals Work Much Faster and Much Better
PRESSURE BIOSCIENCES ANNOUNCES TECHNOLOGY TO MAKE CBD, THC, AND MANY PHARMACEUTICALS, COSMETICS, AND NUTRACEUTICALS WORK MUCH FASTER AND BETTER
-
Oil based products containing active ingredients to treat a wide spectrum of indications are common and often costly ingredients of CBD, THC, pharma, cosmetics and nutraceuticals
-
All the oils in all these products that contain the active ingredients naturally occur only in large drops that are difficult for the human body to absorb the active ingredients within the oil. Typically, only 5% of oils delivered to the human body are absorbed while close to 95% is unused and rejected as waste
-
Pressure BioSciences announced their UltraShear device dramatically reduces the size of the oil drops that contain the active ingredients to nano sized droplets which allows the body to absorb 4 to 5 times more of the active ingredients than conventional oil drops, and do it much faster. Testing has shown this nano sized droplet can make an active ingredient far more bioavailable and work in 5 minutes versus 40 minutes.
-
UltraShear also enables CBD, THC, pharma, cosmetics and nutraceutical companies to cut costs by reducing the amount of active ingredients in their products by at least one-half and with the potential to increase sales and prices due to greater and faster efficacy
-
Shares of Pressure BioSciences, Inc., (PBIO: OTCQB) are selling at $.45 with a market cap of about $10 million
This report is about a little-known microcap, Pressure BioSciences, Inc. (PBIO: OTCQB) that is about to make the sales of billions of dollars of blockbuster products cheaper to make and at the same time make them work a lot better and a lot faster than the competition. Companies that are first to adopt Pressure BioSciences new UltraShear technology could claim insurmountable advantages over the competition. Their costs could be lower, and their products could work better and faster. Imagine what could happen to the sales of any company that promoted the message that their products worked far better and far faster than the competition.
Oil Based Products Are Prevalent and Haven’t Changed in Centuries
Oil based products with various active ingredients are prevalent in large industries such as, CBD, THC, Pharmaceuticals, Cosmetics and Nutraceuticals. Combined, these industries move over a trillion dollars per year in products and oils are commonly used ingredients that make up a large part of these sales.
For centuries, oil could only be separated into its smallest unit called a drop or a droplet. Because these drops are relatively large compared to molecules, the active ingredients within the oil do not absorb well into the human body. It is known that only approximately 5% of oil that is delivered to the human body is absorbed while about 95% is not absorbed and is excreted as waste.
Pressure BioSciences Makes Oil Droplets So Tiny You Can’t See Them
What if there was a way to shrink the size of an oil drop down to the size of a nanoparticle?
This is precisely what Pressure BioSciences UltraShear device does. It shrinks oil drops down to extremely tiny nanosized droplets that are close to the size of a wavelength of light. And they remain stable and stay tiny for long durations. A recent study showed that these nanosized droplets that carry the same identical active ingredients absorb into the human body at least 4 times more efficiently than traditional oil drops. And they absorb far more rapidly. Tests with THC have demonstrated that when the oil drop carrying the active ingredient of THC is reduced in size through the UltraShear device, the drug works in 5 minutes rather than the typical 40 minutes when ingested orally. And since more of the active ingredient is absorbed, less is required to produce the same effect.
The company recently announced, “Peer-Reviewed Scientific Study Independently Confirms Pressure BioSciences’ UltraShear Nanoemulsion Platform Vastly Outperforms Current Technologies, Delivering CBD with Unprecedented Speed, Efficiency, Reliability, and Bioavailability”. The study "Absorption and Bioavailability of Novel UltraShear Nanoemulsion of Cannabidiol in Rats" was published on November 7, 2023 in the peer-reviewed journal Medical Cannabis and Cannabinoids.
Dr. Mahmoud A. ElSohly, a globally-renowned cannabis/natural products researcher of ElSohly Laboratories, Inc., said, “PBIO's UltraShearTM nanoemulsified CBD achieved unparalleled efficiency of oral-GI CBD absorption and systemic bioavailability of active CBD. Our team was surprised by the results of the oral-GI ingestion of UltraShear Nano CBD, with blood levels detected and rising so quickly that it looked almost like instant absorption! It completely eclipsed by at least 4X the current widely-reported CBD bioavailability of approximately 6%."
How Valuable Is UltraShear?
This concept of nanosized oil droplets is not well known but the science strongly suggests an exceptionally high value for its owner and early industry adopters. If a multi-billion-dollar company making and selling CBD, THC, Pharmaceuticals, Nutraceuticals or Cosmetics, learned that they could quickly gain enormous advantages over their competition, would they allow their competitor to beat them to market with it? . . . or would they try to lock it up for themselves as long as possible? Big sales of hundreds of products are at stake and it should not take too long for substantial partnerships to begin unfolding.
Pressure BioSciences Has Large Reach Through its Customer Base and is Rapidly Switching from R&D Lab Equipment to Manufacturing
Pressure BioSciences has Already Proven UltraShear Works on 10 Popular Oils and Believes It Will Work On Every Oil
Conclusion
The UltraShear Platform could potentially enjoy enormous success in many markets, including pharmaceuticals, nutraceuticals, cosmetics, CBD, THC, inks, paints, and more. One outstanding factor is that while most new and disruptive technologies require a long time to gain industry adoption, UltraShear may find exactly the opposite because every potential user will want to be first so they can leap ahead of their competition. Investors searching for opportunities are encouraged to look at Pressure BioSciences and their UltraShear Platform that is currently being developed for commercialization. Shares are trading at about $.45 with a market cap of about $10 million.
Legal Disclosures and Disclaimers
Green Planet Microcaps is not a registered investment adviser. The information that we provide from our website or newsletters is not, and should not be construed in any manner, to be investment advice. All opinions and information provided on this site are for educational and research purposes. Green Planet Microcaps encourages all readers to do their own due diligence and research when determining which investment strategies are best suited for them or to seek the advice of an investment professional.
Any information provided by Green Planet Microcaps should not be construed by any subscriber or prospective subscriber as a solicitation by Green Planet Microcaps to effect, or attempt to effect, any transaction in any security. Investments in the securities markets, and especially in private securities of small start-up companies, are incredibly and highly speculative and involve substantial risk that your entire investment could be lost. The information that we provide or that is derived from our website and/or newsletters should not be a substitute for advice from an investment professional. We encourage you to obtain personal advice from your professional investment advisor and to make independent investigations before acting on the information that you obtain from Green Planet Microcaps or derive from our website and/or newsletters. Only you can determine what level of risk is appropriate for you.
Specifically, we advise all readers and subscribers to seek advice from a registered professional securities representative before deciding to purchase or trade in stocks or any securities presented on this website and/or in a particular newsletter. All information provided regarding the companies featured comes from the companies themselves, SEC filings, news releases, private placement memoranda, company websites as well as other sources of publicly available information. The profiles of these highlighted public and private companies are not in any way a solicitation or recommendation to buy, sell, or hold these or any other securities.
Most of the information on our website and/or newsletters or that we otherwise provide is derived directly from information published by the companies on which we report and/or from other sources we believe are reliable, without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. The information may contain discussions of, or provide access to, certain positions and recommendations as of a specific date. Due to various factors, including, but not limited to, changing market conditions, such discussions and positions/recommendations may no longer be reflective of current discussions and positions/recommendations. We do not in any way warrant or guarantee the success of nor endorse any action which you take in reliance on the information that we provide or that is derived from our website.
Investors should not rely solely on the information contained on this website or in any specific newsletter. Rather, investors should use the information contained on this Website and/or in newsletters as a starting point for doing additional independent research on the featured private and public companies. The advertisements within this newsletter are not to be construed as offers to purchase securities in the companies which may be the subject of such advertisements pursuant to federal or state law or the laws of any foreign jurisdiction.
Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through the use of words such as “projects”, “foresee”, “expects’”, “will,” “anticipates,” “estimates,” “believes,” “understands” or that by statements indicating certain actions “may,” “could,” or “might” occur. There is no guarantee past performance will be indicative of future results. The accuracy or completeness of the information in this newsletter is only as reliable as the sources they were obtained from.
Green Planet Microcaps was compensated $1,250 for this article and will not be liable for any consequential, incidental, punitive, special, exemplary or indirect damages resulting directly or indirectly from the use of or reliance upon any material provided by Green Planet Microcaps or derived from Green Planet Microcap’s website and/or newsletters. Green Planet Microcaps shall not be responsible or liable for any loss or damages related to, either directly or indirectly, (1) any decline in market value or loss of any investment; (2) a subscriber’s inability to use or any delay in accessing Green Planet Microcaps website or any other source of material provided by Green Planet Microcaps including newsletters; (3) any absence of material on Green Planet Microcaps; (4) Green Planet Microcaps failure to deliver or delay in delivering any material or (5) any kind of error in transmission of material. Green Planet Microcaps and each subscriber acknowledge that, without limitation, the above-enumerated conditions cannot be the probable result of any breach of any agreement between Green Planet Microcaps and the subscriber.
Green Planet Microcaps is not affiliated with any brokerage firm and does not endorse or recommend any specific brokerage firm. Green Planet Microcaps is not and will not be responsible for any trades made by a broker on the subscriber’s behalf under any circumstances.